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The  purpose  of this  study  was  to identify  tools  for  the  assessment  of  nutritional  status  in head  and  neck
cancer  patients,  to evaluate  the impact  of malnutrition  on  therapeutic  management  and  quality  of  life
and to propose  a simple  screening  approach  adapted  to routine  clinical  practice.  The  authors  conducted  a
review  of  the  literature  to identify  tools  for the assessment  of nutritional  status  in head  and  neck  cancer
patients  published  in French  and  English.  Articles  were  obtained  from  the PubMed  database  and  from
the  references  of  these  articles  and  selected  journals,  using  the  keywords:  “nutritional  assessment”,  and
“head and neck”  and  “cancer”.  Anthropometric  indices,  laboratory  parameters,  dietary  intake  assessment,
clinical  scores  and  nutritional  risk  scores  used  in patients  with head  and  neck  cancers  are  presented.  The
relevance  of these  tools  in  clinical  practice  and  in  research  is  discussed,  together  with  the  links  between
nutritional  status  and  quality  of life.  This  article  is  designed  to help  teams  involved  in  the  management
of patients  with  head  and neck  cancer  to choose  the most appropriate  tools  for assessment  of  nutritional
status  according  to  their  resources  and  their  objectives.. Introduction
In France, 75% of patients with head and neck cancer consult
t an advanced stage of the disease [1]. Malnutrition is very com-
on  in patients with these cancers, with a prevalence of about
0% [2]. This malnutrition is exacerbated by treatment, especially
hemoradiotherapy. It has become essential to take nutritional sta-
us into account in the patient’s management, as it determines the
atient’s tolerance of curative treatment. Initiation of radiotherapy
nd/or chemotherapy and especially compliance with continuous
nd complete delivery is a recognized prognostic factor with an
mpact on survival [3].
This article is designed to identify tools for assessment of nutri-
ional status, especially those used in patients with head and neck
ancer, to propose a simple screening approach adapted to routine
linical practice, and to study the impact of nutritional status on
he patient’s quality of life (QoL).
DOI of original article: http://dx.doi.org/10.1016/j.aforl.2014.02.011.
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2. Malnutrition: impact and screening tools
According to Soeters [4], malnutrition is a subacute or chronic
condition, in which variable combinations of nutritional imbal-
ance and inﬂammatory processes are responsible for modiﬁcation
of the body composition (reduction of muscle mass and fat mass)
and alteration of organ functions (immune, muscle and cognitive
deﬁcits).
Malnutrition is commonly observed in cancer patients and is
associated with increased morbidity and mortality [5]. The preva-
lence of malnutrition is estimated to be between 50 to 80%,
depending on the tools used and the populations studied [6], with
a particularly high risk of malnutrition in patients with head and
neck cancer. Malnutrition is a factor of poor prognosis associated
with an increased risk of treatment toxicity and consequently an
increased risk of treatment gaps, resulting in decreased efﬁcacy.
Malnutrition also has an impact on the patient’s quality of life [5].
Malnutrition or a risk of malnutrition must be diagnosed, but
the importance of this diagnosis is often underestimated. Many
screening tools for nutritional risk have been published in the litera-
ture (reviews [7,8]), but no consensus has been reached concerning
their use. A survey conducted among 334 oncologists demonstrated
insufﬁcient detection of malnutrition: two-thirds of oncologists
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id not assess weight loss during the consultation and only 65%
ndicated the importance of malnutrition in terms of toxicity and
orbidity and mortality [9]. Various tools have been proposed to
ssess nutritional status. Nutritionists mainly use anthropometric
arameters and dietary assessment data, sometimes completed by
aboratory data and rating scales. In France, a multidisciplinary
ask force set up by the Fédération nationale des centres de lutte
ontre le cancer (FNCLCC) [French Federation of Cancer Centres]
laborated standards, options and recommendations (SOR) on the
asis of scientiﬁc data in order to deﬁne good dietary practice in
ncology (FNCLCC [10] and Duguet [11]), especially for head and
eck cancers [12]. The Société francophone de nutrition clinique et
étabolisme (SFNEP) has also recently published practice guide-
ines for the diagnosis and management of malnutrition in adult
ancer patients [13].
.1. Anthropometric nutritional indices
Nutritional risk screening based on the use of anthropometric
ndices (Table 1) consists of measuring the patient’s weight loss,
hich remains a decisive element contributing to the nutritional
ssessment. The importance of weight loss has been emphasized
y the FNCLCC [10,11] and the SFNEP [13]. The main parameters
dopted by the FNCLCC (“standards”) also include measurement
f height and current weight, estimation of involuntary weight
oss and the rate of weight loss, and calculation of the body mass
ndex (BMI) (ratio of weight [kg] over height squared [m2]). Weight
oss, expressed as a percentage of normal weight, constitutes a
utritional marker related to poorer survival in cancer patients
together with other markers such as BMI), as a percentage weight
oss greater than 10% is associated with particularly marked excess
ortality [14].
These data must be completed by physical examination (look-
ng for any signs of mucocutaneous deﬁciency, oedema, etc.) and
ssessment of any associated gastrointestinal disorders.
Triceps skin fold thickness and mid-upper arm circumference
re anthropometric parameters that constitute “options” according
o the FNCLCC [10]. However, they are not used in routine clinical
ractice as they are difﬁcult to measure.
.2. Dietary intake assessment
Tumours situated adjacent to or invading the gastrointesti-
al tract are commonly associated with decreased food intake
10]. The various treatments used to treat the cancer frequently
ompromise the patient’s already precarious nutritional status.
atrogenic mucositis can dramatically reduce food intake. Head and
eck irradiation can induce dysphagia with alteration of smell and
aste, associated with decreased salivary secretion depending on
he zones irradiated. These various factors can lead to complete
phagia. Bernier et al. [15] reported that the chemoradiotherapy
ombination in patients with head and neck cancer induced a
igher rate of severe grade 3 and 4 mucositis (41%) compared to
adiotherapy alone (21%); these data were conﬁrmed on a larger
ohort by Cooper et al. [16].
Dietary intake assessment with recording over 24 to 72 hours
nables the dietician to calculate the patient’s energy and pro-
ein intake and to compare this intake to the patient’s optimal
utritional requirements. The various assessment techniques are
isted in Table 2. The FNCLCC [10] uses calculation of food intake
s the standard method. Dietary intake less than 25 kcal/kg/day is
ssociated with a high risk of malnutrition (PNNS1). This essential
1 PNNS 2010: Dénutrition – une pathologie méconnue en société d’abondance :
ttp://www.sante.gouv.fr/les-syntheses-du-pnns.htmlgy, Head and Neck diseases 131 (2014) 113–120
assessment must be performed regularly in order to determine
and then adapt optimal nutritional management according to the
course of nutritional status during treatment.
2.3. Laboratory nutritional parameters
Determination of laboratory parameters (Table 3) such as
albumin or even transthyretin (prealbumin) and markers of inﬂam-
mation such as CRP should ideally be part of the systematic
laboratory work-up at the time of the patient’s admission to hospi-
tal [17]. Postoperative morbidity and mortality have been reported
to be increased in the presence of hypoalbuminaemia [10]. The
cut-off of 35 g/L is used as a prognostic factor in medical oncology.
Transthyretin, a protein with a short half-life (two days), appears
to be a more reliable marker of malnutrition and appears to be
particularly relevant to rapidly evaluate the efﬁcacy of renutrition.
Albumin and transthyretin levels are difﬁcult to interpret in the
presence of an inﬂammatory syndrome, as these markers decrease
in parallel with elevation of plasma cytokines. Interpretation of
these markers must therefore be systematically combined with
assay of CRP (C-reactive protein).
The Prognostic Inﬂammatory and Nutritional Index (PINI) pro-
posed by Ingenbleek and Carpentier [18] combines the analysis
of two  proteins of inﬂammation (CRP and orosomucoid) and two
proteins sensitive to variations of nutritional status (albumin and
transthyretin). This index can be used to classify patients into ﬁve
classes according to the severity of malnutrition, but is not used
in routine clinical practice. It was  proposed for the assessment
of chronic malnutrition and has been validated in paediatric and
elderly populations and constitutes an “option” according to the
FNCLCC criteria [10].
2.4. Nutritional scores
Several scores integrating various clinical or even laboratory
parameters have been elaborated to complete the nutritional
assessment. Some of these scores are used for screening of malnu-
trition (clinical nutritional scores, Table 4), while others are used
for prediction of morbidity related to postoperative complications
(risk scores, Table 5).
2.4.1. Clinical nutritional scores
The Mini Nutritional Assessment (MNA [19]) was developed and
validated in elderly subjects over the age of 65 years, to assess nutri-
tional status (screening) and to quantify the risk of malnutrition. It
comprises a dietary survey as well as a general assessment (depend-
ency, disease, treatment). The short version of the MNA  (MNA-SF)
is recommended by the Haute Autorité de la snté (French National
Authority for Health) to detect malnutrition in the elderly or hospi-
talised patients [20]. The MNA  constitutes an “option” in the elderly
[10].
The Subjective Global Assessment (SGA or Detsky index), rec-
ommended by the ASPEN (American Society for Parenteral and
Enteral Nutrition) assesses the degree of malnutrition by integrat-
ing the degree of weight loss, the severity of gastrointestinal and
clinical signs of malnutrition, functional impairment and associates
the concept of the intensity of any metabolic stress. It allows sim-
ple and reproducible classiﬁcation of patients into three groups:
(A): well nourished, (B): moderate or suspected malnutrition, (C):
severe malnutrition [21]. In particular, the SGA can be used to assess
nutritional status at the time of diagnosis of head and neck cancer
[22].Ottery [23] adapted a self-administered questionnaire derived
from the SGA for use by cancer patients, the PG-SGA (patient-
generated SGA), the only tool speciﬁcally designed to assess
malnutrition in oncology. This self-administered subjective global
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Table  1
Anthropometric indices.
Index Target population Reference/use Deﬁnition of parameters and cut-off values used to
deﬁne malnutrition
Weight loss: % weight loss
(involuntary)
Elderly HASb Age ≥ 70 years: weight loss ≥ 10% in 6 months
Hospitalised adults HASc Age < 70 years: weight loss ≥ 10%
All  subjects PNNSa Malnutrition if weight loss of 5% in 1 month or 10% in
6 months
Cancer [10,11] “Standard”: evaluation of weight variations
“Recommendation”: nutritional intervention
recommended if the patient has lost more than 10% of
usual body weight in 6 months
[13] In medical oncology, weight loss ≥ 5% (compared to
usual weight or healthy weight or in 6 months) is a
factor of poor prognosis (also for surgery if weight loss
≥  10%)
Head and neck cancer [12] Weight loss of 10% in 6 months considered to have a
prognostic value in oncology, requiring urgent
nutritional management
Head and neck cancer [30] Measurement of the percentage weight loss over the
last 6 months. The patient’s weight loss during
radiotherapy for head and neck cancer is limited when
regular, early and adapted nutritional management is
prescribed
Body  mass index (BMI) Current weight/height2 (kg/m2)
Elderly HASb BMI  < 21
Hospitalised adults HASc BMI  < 17
All subjects PNNSa BMI  < 18.5 in adults; BMI  < 21 in the elderly
Cancer [10,11] Calculation of BMI; moderate malnutrition if BMI is
between 60 and 80% of normal (“Standard”)
Head and neck cancer [30] Measurement of BMI; existence of a correlation
between weight variations and BMI  variations
Triceps skinfold thickness [10,11] Moderate malnutrition if triceps skinfold thickness
between 60 and 80% of normal (“option”)
Mid-upper arm
circumference
[10,11] This measurement constitutes an “option”
a PNNS 2010: Dénutrition – une pathologie méconnue en société d’abondance: http://www.sante.gouv.fr/les-syntheses-du-pnns.html
b HAS 2007: Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée: http://www.has-sante.fr/portail/upload/docs/application/pdf/
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c HAS 2003: Évaluation diagnostique de la dénutrition protéino-énergétique 
enutrition recos 2006 09 25 14 20 46 375.pdfutritional assessment is recommended as standard assessment in
his type of population by the American Dietetic Association for the
etection of malnourished subjects or at high risk of malnutrition.
he French version of the PG-SGA is recommended as an “option” by
able 2
ssessment of the subject’s dietary requirements.
Dietary intake assessment Target population References/recomme
Dietary intake All subjects PNNSa
Cancer [10,11] 
[13] 
Head  and neck cancer [10,12] 
24-hour dietary recall Cancer [10,11] 
Dietary record Cancer [10,11] 
a PNNS 2010: Dénutrition – une pathologie méconnue en société d’abondance: http://wwwdultes hospitalisés: http://www.has-sante.fr/portail/upload/docs/application/pdf/the FNCLCC [10]. A weighting score for the various items has been
introduced into the Scored PG-SGA, allowing less subjective inter-
pretation and more accurate monitoring of individual variations
of nutritional status [24]. One of the strong points of the PG-SGA
ndation Deﬁnition of parameters and cut-off values used to deﬁne
malnutrition
Risk of malnutrition if dietary intake < 25 kcal/kg/day
(semiquantitative assessment by dietary record)
Calculation of energy-protein intake ratio (“standard”)
Systematic evaluation of recommended dietary intake, as a
reduction of the recommended intake is a major risk factor for
malnutrition
The recommended daily energy intake is 1600 to 2400 kcal
with a protein intake of about 1.25 to 1.85 g of protein/kg/day
Estimation of dietary intake based on the subject’s description
of  the food ingested over the previous 24 hr. This
measurement is an “option”
Prospective written record, over several days, of dietary intake
with estimation of portions or weights of foods. This
measurement is an “option”
.sante.gouv.fr/les-syntheses-du-pnns.html
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Table 3
Laboratory parameters.
Laboratory parameters Target population References/recommendation Deﬁnition of parameters and cut-off values used to deﬁne
malnutrition
Serum albumin Elderly HASb Age ≥ 70 years, serum albumin < 35 g/L
Hospitalised adults HASc Age < 70 years, serum albumin < 30 g/L
All  subjects PNNSa < 30 g/L: prognostic value, increased mortality
Cancer [10,11] “Option” in the absence of inﬂammatory syndrome
[13] In medical oncology, increased risk of morbidity and mortality
if  < 35 g/L
Transthyretin (Prealbumin) All subjects PNNSa Decreased survival if < 50 mg/L
Cancer [10,11] “Option” in the absence of inﬂammatory syndrome
CRP  All subjects PNNSa Quantiﬁes inﬂammation
PINI: Prognostic Inﬂammatory
and Nutritional Index
[18] Prognostic index in the case of chronic malnutrition
Combines the analysis of two proteins of inﬂammation
(C-reactive protein: CRP and orosomucoid: oro) and two
proteins sensitive to variations in nutritional status (albumin:
alb and transthyretin: prealb)
PINI = oro (mg/L) × CRP (mg/L)/alb (g/L) × prealb (mg/L)
Patient at moderate risk of malnutrition (PINI between 11 and
20); PINI constitutes an “option” according to the FNCLCC [10]
a PNNS 2010: Dénutrition – une pathologie méconnue en société d’abondance: http://www.sante.gouv.fr/les-syntheses-du-pnns.html
b HAS 2007: Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée: http://www.has-sante.fr/portail/upload/docs/application/pdf/
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s that, in addition to recent weight loss, assessment of nutritional
tatus includes symptoms (loss of appetite, nausea, swallowing dif-
culties, etc.), the patient’s dietary intake and functional capacities,
esulting in a particularly relevant multidimensional score [13,25].
tudies using the PG-SGA to evaluate nutritional status in patients
ith head and neck cancer are listed in Table 4.
The ESPEN (European Society for Clinical Nutrition and
etabolism) recommends the MUST (Malnutrition Universal
creening Tool) as screening tool for malnutrition. The MUST
nd NRS-2002 were recently used to detect malnutrition in can-
er patients and to consequently identify patients at high risk of
rolonged hospitalisation [26]; these tools, as well as the MST  (mal-
utrition screening tool), have also been used to identify head and
eck cancer patients presenting the highest nutritional risk [26].
he MST  also constitutes one of the recommended tools to detect
alnutrition and has been validated for use in oncology [17].
.4.2. Nutritional risk scores
These nutritional risk scores combine anthropometric and lab-
ratory indices (Table 5) and are designed to guide decisions
oncerning more intensive nutritional management in certain situ-
tions. They are part of the “options” recommended by the FNCLCC
10].
The Buzby index [27] or Nutrition Risk Index (NRI) combines
erum albumin and weight loss. It is used both for assessment of
utritional status and as a prognostic factor. It is recommended in
he perioperative setting to select patients likely to beneﬁt from
reoperative artiﬁcial nutrition before major surgery. It has been
alidated for use in oncology [17].
The Mullen index (or PNI [28]) is more complex (integrating
lbumin, triceps skinfold thickness, serum transferrin and hyper-
ensitivity skin tests) and is considered to be the only tool able to
rospectively predict the patient’s outcome. The score d’aide déci-
ionnelle à l’assistance nutritive (SADAN) can be used to determine
he need for nutritional support in patients with chronic gastroin-
estinal disease. The PNI and SADAN indices (Table 5) are not used
n routine clinical practice.dultes hospitalisés: http://www.has-sante.fr/portail/upload/docs/application/pdf/
2.4.3. Other methods
Functional and instrumental measurements can also be per-
formed (impedancemetry, calorimetry). Impedancemetry provides
an assessment of muscle mass by measuring the water content
of muscles. Indirect calorimetry provides an assessment of the
patient’s basal energy expenditure. These methods can complete,
but do not replace nutritional assessment. They can be useful in
particular situations, but require speciﬁc equipment and therefore
cannot be used routinely in all centres.
3. Malnutrition: consequences on therapeutic
management and quality of life
3.1. Consequences on therapeutic management
The “standards, options and recommendations” (SOR) task
force [12] highlighted the importance of nutritional management
before, during and after treatment of patients with head and neck
cancer. Regular weight surveillance in all patients was deﬁned
as a “standard” with the need to institute urgent nutritional
management in patients with a weight loss of 10% during the
previous 6 months.
3.1.1. During radiotherapy
Patients treated by radiotherapy require at least weekly weight
surveillance and enteral nutrition must be rapidly considered
when malnutrition becomes threatening despite nutritional man-
agement [12], as it has been clearly established that a mean weight
loss of 4 to 5 kg is commonly observed during radiotherapy for
head and neck cancer in the absence of any particular nutritional
management and justiﬁes early, personalized and regular nutri-
tional surveillance to limit this weight loss [29]. In head and neck
cancer patients treated by radiotherapy, Garabige [30] showed
that early systematic nutritional management signiﬁcantly lim-
ited weight loss, the number of treatment interruptions and
the severity of mucositis. Moreover, the primary importance of
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Table  4
Nutritional clinical scores.
Clinical nutritional scores:
nutritional status and risk of
malnutrition
Validation reference Target population Reference/use Parameters studied/recommendations
MNA: Mini Nutritional
Assessment (global)
(18 items)
[19] Quantiﬁcation of nutritional status or risk of
malnutrition in the elderly
Screening (assessment of nutritional status)
Global assessment (diagnosis of malnutrition or risk of
malnutrition)
Integrates the weight curve, dietary intake, physical
activity, emotional state and anthropometric
measurements
Elderly HASa; [42] HAS: malnutrition if global MNA  < 17
Cancer [10,11,13] MNA: “option” in the elderly
MNA-SF (short-form) (6 items) [20] Hospitalised adults HASb “Screening” part of MNA
Elderly HASa Age ≥ 70 years, MNA-SF ≤ 11
SGA  (Subjective Global
Assessment)
[21] All subjects Assesses the degree of malnutrition based on severity
of  weight loss, severity of gastrointestinal and clinical
signs of malnutrition, functional alteration and
includes the concept of the intensity of metabolic
stress
Validated in French Cancer [10,11,13] SGA is useful to complete assessment of malnutrition
(“option”)
SGA recommended by SFNEP
PG-SGA & scored-PG-SGA (17
items) = self-administered
subjective global nutritional
assessment (validated in
oncology and in French)
[23,24] Cancer Self-assessment of the degree of malnutrition by:
1) weight changes, symptoms, altered dietary intake
and functional capacities.
2) disease and related nutritional requirements
3) clinical examination
[10,13] PG-SGA: French version recommended by FNCLCC
(“option”)
Recommended PG-SGA by SFNEP
Head and neck cancer [17] Only tool speciﬁcally designed for oncology
[25,34,39,41,43–45]
MST  (Malnutrition Screening
Tool)
[46] Hospitalised adults The MST comprises 3 items: involuntary weight loss,
evaluation of this weight loss and food/appetite
[47] Cancer [13,17,26]
MUST (Malnutrition Universal
Screening Tool)
[48] The MUST comprises the percentage involuntary
weight loss, BMI  and presence/absence of acute illness.
Ofﬁcial tool used by the British Dietetic Association,
the Royal College of Nursing, the Registered Nursing
Homes Association, the British Association for
parenteral and enteral nutrition (BAPEN), and ESPEN
(European Society for Clinical Nutrition and
Metabolism)
Adults [42]
Cancer [13,49] According to Boléo-Tomé [49], MUST (widely used in
Europe) should be used as ﬁrst-line tool to identify
patients requiring follow-up, and follow-up is then
adapted according to PG-SGA
[17,26]
NRS (nutrition risk screening)
2002
[50] Rapid identiﬁcation of patients requiring nutritional
management; based on analysis of randomized clinical
trials; patients assessed according to 2 characteristics:
malnutrition (weight loss) and severity of disease
All  patients [50]
Cancer [13,17,26]
a HAS 2007: Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée: http://www.has-sante.fr/portail/upload/docs/application/pdf/
synthese denutrition personnes agees.pdf
b HAS 2003: Évaluation diagnostique de la dénutrition protéino-énergétique des adultes hospitalisés: http://www.has-sante.fr/portail/upload/docs/application/pdf/denutrition
r
n
o
b
Pecos 2006 09 25 14 20 46 375.pdfutritional surveillance in this type of patient and its repercussions
n nutritional parameters (weight), tolerability of treatment,
ut also quality of life, was recently emphasized by the French
rogramme national nutrition santé (PNNS).3.1.2. During chemotherapy
Nutritional surveillance of head and neck cancer patients is rec-
ommended during each cycle of chemotherapy and prolonged total
interruption of oral feeding must be avoided by initiating enteral
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Table 5
Clinical and laboratory scores and risk indices.
Clinical and laboratory scores
and risk indices
Validation reference Target population Reference/use Parameters studied/recommendation
NRI: Nutrition Risk Index
(2 items)
[27] NRI = 1.519 × (albumin in g/L) + 41.7 × (current
weight/usual weight)
Cancer [10,11,13,17] Moderately malnourished patients: NRI between 83.5
and 97.5 (option)
Completes the nutritional assessment of malnourished
subjects (“option”)
PNI:  (Mullen index) [28] PNI% = 1581.66 (alb) 0.78 (TSF) 0.02 (TFN) 5.8 (DH) [alb
=  serum albumin in g/L; TSF: triceps skinfold (mm);
TFN: serum transferrin (mg/L); DH: skin
hypersensitivity test: 0: no reaction; 1 if wheal < 5
mm;  2 if wheal > 5 mm]
Prognostic Nutritional Index Cancer [10,11] Completes the nutritional assessment of malnourished
subjects (“option”)
SADAN: aid to the decision
concerning nutritional
support
Predictive score of the need for nutritional support
SADAN: 826 (5.2 × dietary intake) (3.3 × % weight)
(2.8 × % MUAC) (4.5 × albumin in g/L); dietary intake in
kcal/kg of ideal weight per day; % weight: weight as %
of ideal weight; % MUAC: mid-upper arm
circumference as % of predicted
n
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tCancer 
utrition whenever necessary, when oral intake, even completed
y nutritional supplements, is unable to cover the patient’s energy
nd protein requirements. Enteral nutrition is not routinely recom-
ended during chemotherapy when the patient’s nutritional status
nd/or dietary intake are sufﬁcient (grade A) [31].
.1.3. Cancer surgery
Weight loss is a decisive element for assessment of the opera-
ive risk related to cancer surgery. ESPEN published guidelines for
erioperative nutritional management in 2006 [32]. A nasogastric
nteral nutrition tube must be placed during surgery whenever oral
eeding is expected to be interrupted for several days to avoid com-
romising the patient’s nutritional status and therefore to ensure
ptimal healing conditions. Enteral nutrition should be started on
ostoperative D1 and is then rapidly and progressively increased
12].
The FNCLCC has proposed decisional ﬂow diagrams adapted
o head and neck cancer patients corresponding to the situations
ncountered before and during the various treatments, postop-
ratively and at the time of the patient’s discharge from hospital
12].
.2. Consequences on quality of life
Malnutrition in cancer patients alters their quality of life [10],
articularly in the case of cancers that are difﬁcult to treat, such
s head and neck cancers. The recent review by Lis et al. [33]
xamined the impact of nutritional status on the quality of life of
ancer patients. Out of the 26 publications reviewed, 24 concluded
hat better nutritional status was associated with improved quality
f life. Six of these publications were exclusively devoted to head
nd neck cancers [1,34–38]. Various tools were used to assess
utritional status, but weight loss was one of the parameters
valuated in ﬁve studies. Weight loss was usually evaluated
lone [1,35–37], or in combination with PG-SGA [34] or other
nthropometric indices (mid-upper arm circumference and triceps
kinfold thickness), weight index (current weight divided by the
eference weight for height), BMI  and serum albumin [38]. The
ools mainly used to evaluate quality of life are the EORTC-QLQ-C30[10,11] Completes the nutritional assessment of malnourished
subjects (“option”)
questionnaire, used in ﬁve studies, either alone [1,34] or in com-
bination with the EORTC-QLQ-H& N-35 module speciﬁc to head
and neck cancer [36] or with an equivalent questionnaire [38]. The
two EORTC tools were associated with the Hospital Anxiety and
Depression Scale (HADS) in the study by Petruson [37].
These six studies on head and neck cancer quoted by Lis et al.
[33] all concluded that a better nutritional status was positively
correlated with better quality of life. Each study evaluated the role
of the various parameters likely to inﬂuence this correlation. For
example, Morton et al. [35] reported an association between weight
loss and decreased speech and swallowing functions, leading to
decreased oral food intake. Van den Berg [36] concluded that weight
loss of more than 10% at the time of the diagnosis signiﬁcantly
impacted quality of life scores and worsened not only global qual-
ity of life, but also fatigue and pain. This study also suggested the
value of limiting weight loss as much as possible from the time of
the diagnosis and for the ﬁrst 6 months after treatment. Petruson
[37] showed that patients with more than 10% of weight loss over
a period of 6 months corresponded to those patients with the most
severely impaired quality of life and also showed that quality of
life was a predictive factor of weight loss in head and neck cancer
patients. In the study by Capuano [34], total weight loss of more
than 20% was signiﬁcantly correlated with treatment interruption,
infections, early mortality, post-treatment readmission and sur-
vival.
Although the percentage weight loss since onset of the disease
appears to be a relatively objective parameter, it does not take
into account either the kinetics of weight loss or the presence of
oedema or ﬂuid retention and other clinical and laboratory effects.
A tool like the PG-SGA therefore constitutes one of the most reli-
able parameters to assess nutritional status. The results reported
by Capuano [34] showed a strong correlation between involuntary
weight loss and PG-SGA. This tool has often been correlated with
various prognostic criteria, including quality of life, especially in
head and neck cancers [39]. The authors of the review concluded
that nutritional status is a highly predictive factor of quality of life
and that correction of malnutrition (by renutrition) could have a
beneﬁcial effect on the quality of treatment response in cancer
patients and a positive impact on their quality of life [33].
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. Practical recommendations
Simple screening for malnutrition must be performed system-
tically and early in the course of the disease, i.e. at the time
f the ﬁrst visit at which the diagnosis is announced and must
hen be regularly repeated at each visit to follow the course of
eight. This assessment must at least comprise measurement of
eight and weight loss plotted on a time scale, as well as cal-
ulation of BMI. It must be combined with rapid assessment of
ral dietary intake, with the assistance of a dietician whenever
ossible, or otherwise by using scales to estimate the portions
ngested, for example dietary intake analogue scales [40]. In prac-
ice, the clinician must monitor the patient for warning signs such
s dysphagia, xerostomia or decreased dietary intake (less than
wo-thirds of the usual dietary intake), possibly associated with
ven minimal weight loss, indicating the need for appropriate
utritional management. Early nutritional intervention is more
ffective than delaying intervention until the stage of excessive
eight loss, which is more difﬁcult to treat and treatment may
ometimes less effective when the patient has already developed
dvanced cachexia.
Dietary advice must be based on personalized patient man-
gement prior to any treatment with weekly follow-up until the
nd of treatment and assessment 1 to 3 months after completion
f radiotherapy or chemoradiotherapy. Nutritional management
ust cover the patient’s daily energy requirements by taking into
ccount the patient’s eating habits and the adverse effects of treat-
ents. The studies by Ravasco [41] showed that dietary advice was
ore effective than nutritional supplements prescribed alone, as
nly patients receiving dietary advice maintained or improved their
uality of life during radiotherapy. After three months, a signiﬁcant
0% reduction of the incidence of grade A and B toxicities (anorexia,
ausea, vomiting, xerostomia and dysgeusia) was also observed in
he dietary advice group versus 67% in the oral supplement group
nd 51% in the oral feeding only group. A dietetic consultation is
herefore recommended in all patients receiving radiotherapy for
ead and neck cancer (grade B) [31]. However, it would be illusory
o try to meet the patient’s energy and protein requirements by sim-
le oral nutritional supplements when dysphagia is already severe
r in the presence of marked anorexia; in these settings, enteral
utrition by nasogastric probe or gastrostomy, depending on the
ituation, should be initiated without delay. Prophylactic gastros-
omy should be considered before chemoradiotherapy involving
he oral cavity, due to the risk of development or deterioration
f dysphagia, particularly in previously malnourished patients or
hen the irradiation ﬁeld includes the oropharynx [31]. Finally, the
se of pharmaconutrients during chemoradiotherapy is not recom-
ended on the basis of the current data of the literature (grade C)
31]; although some data support the use of pharmaconutrients,
hese ﬁndings need to be validated by comparative studies based
n larger sample sizes.
In the perioperative setting, weight loss and the SGA appear to
e the most appropriate nutritional markers and must therefore
e evaluated. For patients who are malnourished preoperatively,
ystematic management of malnutrition is recommended on the
asis of the following criteria: weight loss greater than 10–15%
uring the previous six months; body mass index less than 18.5,
rade C SGA or serum albumin less than 30 g/L. Ideally, artiﬁcial
utrition should be initiated 10 to 14 days before surgery, via the
nteral route whenever possible [32]. The patient’s enteral nutri-
ion must be continued postoperatively after major head and neck
urgery (grade A), in patients who are malnourished preoperatively
grade A) but also in non-malnourished patients when oral intake
s likely to be less than 60% of the target energy intake during the
rst 10 days after surgery (grade C), according to ESPEN guidelines
32].gy, Head and Neck diseases 131 (2014) 113–120 119
When anthropometric measurements cannot be interpreted,
serum albumin or serum prealbumin may  be helpful, in the absence
of an associated marked inﬂammatory syndrome, or renal or liver
failure.
In patients at high risk of malnutrition, such as patients with
head and neck cancer, the FNCLCC recommends use of the PG-
SGA as systematic screening tool to monitor individual variations of
nutritional status and to demonstrate minor modiﬁcations of this
status, including in response to nutritional intervention. This tool,
speciﬁcally designed for cancer patients, is very commonly used in
scientiﬁc publications devoted to nutritional assessment of head
and neck cancer patients, but its use in routine clinical practice
remains limited.
5. Conclusion
Nutritional assessment is essential in view of the morbidity,
complications and impaired quality of life induced by malnutrition.
Optimization of the nutritional management of head and neck
cancer patients must constitute a major objective for therapists,
alongside treatment of the cancer itself. The ﬁrst “cancer plans”
instituted in France have enabled us to partly regain lost ground in
this ﬁeld in comparison to other European countries.
Nutritional assessment must be simple, effective, adapted and
reproducible in order to allow early and effective nutritional man-
agement. In the absence of a validated approach and an ideal
assessment tool, the nutritional assessment of head and neck can-
cer patients must be based on a combination of various parameters
comprising anthropometric, dietary and clinical and laboratory
data. The tools described here do not constitute a rigorous approach
(the gold standard does not exist), but constitute a guide so that
each team can choose the most appropriate nutritional assessment
adapted to its resources.
Disclosure of interest
The authors declare that they have no conﬂicts of interest con-
cerning this article.
Acknowledgements
The authors would like to thank Ghislaine Mivielle and the Caen
university hospital and Franc¸ ois Baclesse cancer centre nutrition
teams for their daily assistance in the management of head and
neck cancer patients.
References
[1] Jager-Wittenaar H, Dijkstra PU, Vissink A, et al. Malnutrition and quality of life
in  patients treated for oral or oropharyngeal cancer. Head Neck 2011;33:490–6.
[2] Hébuterne X, Lemarié E, Michallet M,  et al. Prévalence de la dénutrition au cours
du  cancer : une enquête nationale un jour donné. Nutr Clin Metab 2006;20:S86.
[3] Duncan W,  MacDougall RH, Kerr GR, et al. Adverse effect of treatment
gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol
1996;41:203–7.
[4] Soeters PB, Reijven PL, van Bokhorst-de van der Schueren MA,  et al. A rational
approach to nutritional assessment. Clin Nutr 2008;27:706–16.
[5] Van Cutsem E, Arends J. The causes and consequences of cancer-associated
malnutrition. Eur J Oncol Nurs 2005;9(Suppl 2):S51–63.
[6] Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and
their relationship to quality of life and clinical outcomes in medical oncology
patients. Support Care Cancer 2009;17:83–90.
[7] Green SM, Watson R. Nutritional screening and assessment tools for use by
nurses: literature review. J Adv Nurs 2005;50:69–83.[8] Jones JM.  The methodology of nutritional screening and assessment tools. J
Hum Nutr Diet 2002;15:59–71, quiz 73-5.
[9] Spiro A, Baldwin C, Patterson A, et al. The views and practice of oncologists
towards nutritional support in patients receiving chemotherapy. Br J Cancer
2006;95:431–4.
1 yngolo
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[20 V. Prevost et al. / European Annals of Otorhinolar
10] FNCLCC (Fédération nationale des centres de lutte contre le cancer). Bonnes
pratiques diététiques en cancérologie : dénutrition et évaluation nutritionnelle.
Nut Clin Métab 2002;16:97–124.
11] Duguet A, Bachmann P, Lallemand Y, et al. Good clinical practice in nutritional
management in cancer patients: malnutrition and nutritional assessment. Bull
Cancer 1999;86:997–1016.
12] Meuric J, Garabige V, Blanc-Vincent MP,  et al. Good clinical practice in
nutritional management of head and neck cancer patients. Bull Cancer
1999;86:843–54.
13] Senesse P, Vasson MP,  Groupe de travail de la Société francophone de nutri-
tion clinique et métabolisme. Nutrition chez le patient adulte atteint de cancer:
quand et comment évaluer l’état nutritionnel d’un malade atteint de cancer ?
Comment faire le diagnostic de dénutrition et le diagnostic de dénutrition
sévère chez un malade atteint de cancer ? Quelles sont les situations les plus à
risque de dénutrition ? Nut Clin Metab 2012;26:165–88.
14] Di Fiore F, Lecleire S, Rigal O, et al. Predictive factors of survival in patients
treated with deﬁnitive chemoradiotherapy for squamous cell esophageal car-
cinoma. World J Gastroenterol 2006;12:4185–90.
15] Bernier J, Domenge C, Ozsahin M,  et al. Postoperative irradiation with or with-
out concomitant chemotherapy for locally advanced head and neck cancer. N
Engl J Med 2004;350:1945–52.
16] Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy
and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
N Engl J Med  2004;350:1937–44.
17] Antoun S, Baracos V. Malnutrition in cancer patient: when to have a specialize
consultation? Bull Cancer 2009;96:615–23.
18] Ingenbleek Y, Carpentier YA. A prognostic inﬂammatory and nutritional index
scoring critically ill patients. Int J Vitam Nutr Res 1985;55:91–101.
19] Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly:
the  Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev
1996;54(1 Pt 2):S59–65.
20] Rubenstein LZ, Harker J, Guigoz Y, et al. Comprehensive geriatric assessment
(CGA) and the MNA: an overview of CGA, nutritional assessment, and devel-
opment of a shortened version of the MNA. Nestle Nutr Workshop Ser Clin
Perform Programme 1999;1:101–15, discussion 115-6.
21] Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment
of  nutritional status? J Parenter Enteral Nutr 1987;11:8–13.
22] Righini CA, Timi N, Junet P, et al. Assessment of nutritional status at the time of
diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryn-
gol Head Neck Dis 2013;130:8–14.
23] Ottery FD. Deﬁnition of standardized nutritional assessment and interventional
pathways in oncology. Nutrition 1996;12(1 Suppl):S15–9.
24] McMahon K, Decker G, Ottery FD. Integrating proactive nutritional assessment
in clinical practices to prevent complications and cost. Semin Oncol 1998;25(2
Suppl 6):20–7.
25] Schmidt KN, Olson K, Kubrak C, et al. Validation of the head and neck patient
symptom checklist as a nutrition impact symptom assessment tool for head
and neck cancer patients. Support Care Cancer 2013;21:27–34.
26] Amaral TF, Antunes A, Cabral S, et al. An evaluation of three nutri-
tional screening tools in a Portuguese oncology centre. J Hum Nutr Diet
2008;21:575–83.
27] Buzby GP, Knox LS, Crosby LO, et al. Study protocol: a randomized clinical trial
of  total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr
1988;47(2 Suppl):366–81.28] Mullen JL, Buzby GP, Waldman MT,  et al. Prediction of operative morbidity and
mortality by preoperative nutritional assessment. Surg Forum 1979;30:80–2.
29] Isenring EA, Capra S, Bauer JD. Nutrition intervention is beneﬁcial in oncology
outpatients receiving radiotherapy to the gastrointestinal or head and neck
area. Br J Cancer 2004;91:447–52.
[
[gy, Head and Neck diseases 131 (2014) 113–120
30] Garabige V, Giraud P, De Rycke Y, et al. Impact of nutrition management in
patients with head and neck cancers treated with irradiation: is the nutritional
intervention useful? Cancer Radiother 2007;11:111–6.
31] Senesse P, Bachmann P, Bensadoun RJ, et al. Nutrition chez le patient adulte
atteint de cancer: textes courts. Nut Clin Metab 2012;26:151–8.
32] Weimann A, Braga M,  Harsanyi L, et al. ESPEN Guidelines on Enteral Nutrition:
surgery including organ transplantation. Clin Nutr 2006;25:224–44.
33] Lis CG, Gupta D, Lammersfeld CA, et al. Role of nutritional status in predicting
quality of life outcomes in cancer – a systematic review of the epidemiological
literature. Nutr J 2012;11:27.
34] Capuano G, Gentile PC, Bianciardi F, et al. Prevalence and inﬂuence of malnutri-
tion on quality of life and performance status in patients with locally advanced
head and neck cancer before treatment. Support Care Cancer 2010;18:433–7.
35] Morton RP, Crowder VL, Mawdsley R, et al. Elective gastrostomy, nutritional
status and quality of life in advanced head and neck cancer patients receiving
chemoradiotherapy. ANZ J Surg 2009;79:713–8.
36] van den Berg MG,  Rasmussen-Conrad EL, van Nispen L, et al. A prospective
study on malnutrition and quality of life in patients with head and neck cancer.
Oral  Oncol 2008;44:830–7.
37] Petruson KM,  Silander EM,  Hammerlid EB. Quality of life as predictor of weight
loss  in patients with head and neck cancer. Head Neck 2005;27:302–10.
38] Hammerlid E, Wirblad B, Sandin C, et al. Malnutrition and food intake in rela-
tion  to quality of life in head and neck cancer patients. Head Neck 1998;20:
540–8.
39] Isenring E, Bauer J, Capra S. The scored patient-generated subjective global
assessment (PG-SGA) and its association with quality of life in ambulatory
patients receiving radiotherapy. Eur J Clin Nutr 2003;57:305–9.
40] Thibault R, Goujon N, Le Gallic E, et al. Use of 10-point analogue scales to esti-
mate dietary intake: a prospective study in patients nutritionally at-risk. Clin
Nutr 2009;28:134–40.
41] Ravasco P, Monteiro-Grillo I, Marques Vidal P, et al. Impact of nutrition on
outcome: a prospective randomized controlled trial in patients with head and
neck  cancer undergoing radiotherapy. Head Neck 2005;27:659–68.
42] Kondrup J, Allison SP, Elia M, et al. Educational and Clinical Practice Committee.
European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines
for  nutrition screening 2002. Clin Nutr 2003;22:415–21.
43] Britton B, Clover K, Bateman L, et al. Baseline depression predicts malnutrition
in  head and neck cancer patients undergoing radiotherapy. Support Care Cancer
2012;20:335–42.
44] DeCicco PV, Wunderlich SM,  Emmolo JS. Determination of malnourishment in
the  head and neck cancer patient: assessment tools and nutrition education of
radiation oncologists. Support Care Cancer 2011;19:123–30.
45] Jeffery E, Sherriff J, Langdon C. A clinical audit of the nutritional status and
need for nutrition support amongst head and neck cancer patients treated with
radiotherapy. Australas Med  J 2012;5:8–13.
46] Ferguson M,  Capra S, Bauer J, et al. Development of a valid and reliable mal-
nutrition screening tool for adult acute hospital patients. Nutrition 1999;15:
458–64.
47] Ferguson ML, Bauer J, Gallagher B, et al. Validation of a malnutrition screening
tool for patients receiving radiotherapy. Australas Radiol 1999;43:325–7.
48] Elia. Screening for malnutrition: a multidisciplinary responsibility. Develop-
ment and use of the “malnutrition universal screening tool” (“MUST”) for
adults. Malnutrition Advisory Group, a Standing Committee of BAPEN. Red-
ditch: BAPEN; 2003.49] Boléo-Tomé C, Monteiro-Grillo I, Camilo M,  et al. Validation of the malnutrition
universal screening tool (MUST) in cancer. Br J Nutr 2012;108:343–8.
50] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS
2002): a new method based on an analysis of controlled clinical trials. Clin Nutr
2003;22:321–36.
